Company Number: 14582734

Analysis Date: 2025-07-19 11:51 UTC

1. Risk Rating: MEDIUM
   The company is newly incorporated (2023) and maintains a very small scale of operations, reflected in micro-entity accounting and minimal net assets (£90). While solvency appears adequate with net current assets positive, the small capital base and director-related transactions suggest potential liquidity and operational risks.

2. Key Concerns:

• Minimal Financial Resources: The net assets and working capital are very low (£90), indicating limited financial cushion against adverse events.
• Director-Related Transactions: The accounts show significant transactions involving the director, including expenses paid on his behalf (£57,540) and funds introduced (£49,985), which may indicate reliance on director financing rather than operational revenue.
• Limited Financial Transparency: The company filed filleted accounts without a profit and loss account, restricting insight into operational performance and cash flows.

3. Positive Indicators:

• Current Filing Compliance: Both accounts and confirmation statements are up to date with no overdue filings, suggesting good regulatory adherence so far.
• Positive Net Current Assets: Despite small amounts, the company reports positive net current assets, indicating the ability to cover short-term liabilities at the balance sheet date.
• Director Control and Stability: Ownership and control are concentrated in a single director who is actively engaged, potentially facilitating swift decision-making.

4. Due Diligence Notes:

• Review the nature and terms of director-related transactions to assess any repayment obligations or contingent liabilities.
• Obtain or request management accounts or profit and loss data to evaluate operational performance and cash flow generation potential.
• Assess the business model and revenue streams, given the SIC code (86900 - other human health activities), to understand sustainability prospects.
• Confirm absence of any director disqualifications or regulatory issues beyond Companies House filings.